Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

347 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Inhibition of Lithium Sensitive Orai1/ STIM1 Expression and Store Operated Ca2+ Entry in Chorea-Acanthocytosis Neurons by NF-κB Inhibitor Wogonin.

Sukkar B, Hauser S, Pelzl L, Hosseinzadeh Z, Sahu I, Al-Maghout T, Bhuyan AAM, Zacharopoulou N, Stournaras C, Schöls L, Lang F.

Cell Physiol Biochem. 2018;51(1):278-289. doi: 10.1159/000495229. Epub 2018 Nov 19.

0

0

0

PUBMED

Chorea revealing systemic lupus erythematosus in a 13-year old boy: A case report and short review of the literature.

Athanasopoulos E, Kalaitzidou I, Vlachaki G, Stefanaki S, Tzagkaraki A, Niotakis G, Tritou I, Ladomenou F.

Int Rev Immunol. 2018 Mar 29:1-6. doi: 10.1080/08830185.2018.1452920. [Epub ahead of print]

0

0

0

PUBMED

Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease.

Covey DP, Dantrassy HM, Yohn SE, Castro A, Conn PJ, Mateo Y, Cheer JF.

Neuropsychopharmacology. 2018 Jun 1. doi: 10.1038/s41386-018-0107-8. [Epub ahead of print]

0

0

0

PUBMED

Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease.

Di Pardo A, Castaldo S, Amico E, Pepe G, Marracino F, Capocci L, Giovannelli A, Madonna M, van Bergeijk J, Buttari F, van der Kam E, Maglione V.

Hum Mol Genet. 2018 Jul 15;27(14):2490-2501. doi: 10.1093/hmg/ddy153.

0

0

0

PUBMED

Functional Magnetic Resonance Imaging in Huntington's Disease.

Gregory S, Scahill RI.

Int Rev Neurobiol. 2018;142:381-408. doi: 10.1016/bs.irn.2018.09.013. Epub 2018 Oct 29.

0

0

0

PUBMED

Design of Bivalent Nucleic Acid Ligands for Recognition of RNA-Repeated Expansion Associated with Huntington's Disease.

Thadke SA, Perera JDR, Hridya VM, Bhatt K, Shaikh AY, Hsieh WC, Chen M, Gayathri C, Gil RR, Rule GS, Mukherjee A, Thornton CA, Ly DH.

Biochemistry. 2018 Mar 27. doi: 10.1021/acs.biochem.8b00062. [Epub ahead of print]

0

0

0

PUBMED

Anorectal Dysfunction in Presymptomatic Mutation Carriers and Patients with Huntington's Disease.

Kobal J, Matej K, Koželj M, Podnar S.

J Huntingtons Dis. 2018 Jun 4. doi: 10.3233/JHD-170280. [Epub ahead of print]

0

0

0

PUBMED

A Patient-Derived Cellular Model for Huntington's Disease Reveals Phenotypes at Clinically Relevant CAG Lengths.

Hung CL, Maiuri T, Bowie LE, Gotesman R, Son S, Falcone M, Giordano JV, Gillis T, Mattis V, Lau T, Kwan V, Wheeler V, Schertzer J, Singh K, Truant R.

Mol Biol Cell. 2018 Sep 26:mbcE18090590. doi: 10.1091/mbc.E18-09-0590. [Epub ahead of print]

0

0

0

PUBMED

Phenytoin induced chorea: a rare adverse effect of the drug.

Patel DM, Gurumukhani JK, Patel MV, Patel GR.

Curr Drug Saf. 2018 Oct 31. doi: 10.2174/1574886313666181031161215. [Epub ahead of print]

0

0

0

PUBMED

Cerebrospinal fluid neurogranin and TREM2 in Huntington's disease.

Byrne LM, Rodrigues FB, Johnson EB, De Vita E, Blennow K, Scahill R, Zetterberg H, Heslegrave A, Wild EJ.

Sci Rep. 2018 Mar 9;8(1):4260. doi: 10.1038/s41598-018-21788-x.

0

0

0

PUBMED

Pathophysiology in the suprachiasmatic nucleus in mouse models of Huntington's disease.

Kuljis D, Kudo T, Tahara Y, Ghiani CA, Colwell CS.

J Neurosci Res. 2018 Aug 31. doi: 10.1002/jnr.24320. [Epub ahead of print]

0

0

0

PUBMED

Chorea, psychosis, acanthocytosis, and prolonged survival associated with ELAC2 mutations.

Paucar M, Pajak A, Freyer C, Bergendal Å, Döry M, Laffita-Mesa JM, Stranneheim H, Lagerstedt-Robinson K, Savitcheva I, Walker RH, Wedell A, Wredenberg A, Svenningsson P.

Neurology. 2018 Sep 14. pii: 10.1212/WNL.0000000000006320. doi: 10.1212/WNL.0000000000006320. [Epub ahead of print] No abstract available.

0

0

0

PUBMED

Statin use and delayed onset of Huntington's disease.

Schultz JL, Nopoulos PC, Killoran A, Kamholz JA.

Mov Disord. 2018 Dec 21. doi: 10.1002/mds.27591. [Epub ahead of print]

0

0

0

PUBMED

Predicting clinical diagnosis in Huntington's disease: An imaging polymarker.

Mason SL, Daws RE, Soreq E, Johnson EB, Scahill RI, Tabrizi SJ, Barker RA, Hampshire A.

Ann Neurol. 2018 Feb 5. doi: 10.1002/ana.25171. [Epub ahead of print]

0

0

0

PUBMED

Are immunotherapies for Huntington's disease a realistic option?

Denis HL, Lauruol F, Cicchetti F.

Mol Psychiatry. 2018 Feb 27. doi: 10.1038/s41380-018-0021-9. [Epub ahead of print] Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy